Comparison of hypnotherapy and standard medical treatment alone on quality of life in patients with irritable bowel syndrome: A randomized control trial

Introduction: Irritable bowel syndrome (IBS) is one of the most prevalent gastroenterological disorders. IBS is characterized by abdominal pain, cramping, diarrhea, constipation, bloating and flatulence. Complementary therapy is a group of diverse therapeutic and health care systems and products that are used in treatment of IBS. Hypnotherapy helps to alleviate the symptoms of a broad range of diseases and conditions. It can be used independently or along with other treatments. Aim: This study was conducted to compare therapeutic effect of hypnotherapy plus standard medical treatment and standard medical treatment alone on quality of life in patients with IBS. Materials and Methods: This study is a clinical trial investigating 60 patients who were enrolled according to Rome-III criteria. The sample size was determined per statistical advice, previous studies, and the formula of sample size calculation. The participants were randomly assigned to two groups of hypnotherapy plus standard medical treatment group (n: 30), and standard medical treatment group (30). The study consisted of three steps; prior to treatment, after treatment and six months after the last intervention (follow-up). The instruments of data gathering were a questionnaire of demographic characteristics and standard questionnaire of quality of life for IBS patients (Quality of Life IBS-34). The data were analysed by analysis of co-variance, Levene’s test and descriptive statistics in SPSS-18. Results: There were significant differences between the two groups of study in post-treatment and follow-up stage with regards to quality of life (p<0.05). Conclusion: Psychological intervention, particularly hypnotherapy, alongside standard medical therapy could contribute to improving quality of life, pain and fatigue, and psychological disorder in IBS patients resistant to treatment. Also, therapeutic costs, hospital stay and days lost from work could be decreased and patients’ efficiency could be increased. © 2016, Journal of Clinical and Diagnostic Research. All rights reserved

Effects of hypnotherapy joint with drug therapy and drug therapy on severity and frequency of the symptoms of patients with irritable bowel syndrome

زمینه و هدف: سندرم روده تحریک پذیر یکی ازشایع ترین اختلالات عملکرد دستگاه گوارش است که با درد شکمی مزمن و تغییردر اجابت مزاج در غیاب هر گونه اختلال عضوی مشخص می شود. هیپنوتراپی در کاهش علائم این بیماری موثر است اما پژوهش های کمی در این زمینه گزارش شده است. هدف از این مطالعه مقایسه اثر بخشی هیپنوتراپی توام با دارو درمانی و دارو درمانی تنها روی فراوانی و شدت علائم بیماران مبتلا به سندرم روده تحریک پذیر بود. روش بررسی: در این مطالعه کارآزمایی بالینی تعداد 34 بیمار دارای علائم غالب اسهال، انتخاب و به صورت تصادفی به دو گروه هیپنوتراپی توام با دارو درمانی و دارو درمانی تنها تقسیم شدند. ابزار اندازه گیری شامل مقیاس فراوانی و شدت علائم روده (BSS-FS) بود که در سه مرحله پیش از مداخلات، پس از مداخلات و شش ماه پس از آخرین مداخلات درمانی بر روی بیماران اجرا گردید. داده های آماری ازطریق آزمون های کولموگراف-اسمیرنف، تحلیل کواریانس (Ancova) و آزمون لوین مورد تجزیه و تحلیل قرار گرفتند. یافته ها: در مرحله پس آزمون اختلاف معنی داری بین گروه هیپنوتراپی توام با دارو درمانی و گروه دارو درمانی تنها در فراوانی و شدت علائم سندرم روده تحریک پذیر وجود داشت (05/0P). نتیجه گیری: به کارگیری هیپنوتراپی در کنار درمان های دارویی می تواند در کاهش فراوانی و شدت علائم بیماران مبتلا به سندرم روده تحریک پذیر، نسبت به دارو درمانی تنها موثرتر باشد، اما عدم استمرار این نوع درمان ها منجر به عود علائم بیماری می شود

Epidemiology of Psychiatric Disorders in Children and Adolescents in Chaharmahal and Bakhtiari Province, Iran, 2017

Background: This study aimed to investigate the epidemiology of psychiatric disorders in children and adolescents in Chaharmahal and Bakhtiari Province of Iran. Methods: This community-based cross-sectional study included 1038 children and adolescents aged 6-18 years from Chaharmahal and Bakhtiari province selected by the multistage cluster sampling method. Samples were interviewed using the Schedule for Affective Disorders and Schizophrenia for School-Age Children. Also, demographic data (gender, age, child education, parent education, and economic situation) were obtained. Binary logistic regression was used to analyze the data. Results: A total of 16.1% of participants were diagnosed to have psychiatric disorders. Total psychiatric disorders were significantly more prevalent in boys than in girls (P = 0.025). Unemployment of fathers was significantly related to increased prevalence of psychiatric disorders in children (P = 0.016). Other demographic variables had no significant correlation with prevalence of psychiatric disorders in children. Anxiety disorders were highly comorbid with behavioral problems (16.4%). Behavioral disorders also had high comorbidity with elimination disorders (16.7%) and substance use disorders (10%). Enuresis was the most frequent psychiatric disorder (5.8%), followed by epilepsy (3.5%), tobacco use (3.4%), and attention deficit hyperactivity disorder (3%). Total anxiety disorders were the most prevalent group of psychiatric disorders in the sample (21.9%), followed by behavioral disorders (16.3%), elimination disorders (8.2%), and neurodevelopmental disorders (4.5%). Conclusion: Our findings suggest that psychiatric disorders affect a significant number of children and adolescents. Prevalence estimates and identification of sources of heterogeneity have important implications to service providers and modifications are needed in mental health services in the community